Guest guest Posted March 15, 2008 Report Share Posted March 15, 2008 Hi all, I've been trying to find more info on Cimetidine's antihistimine/antiviral/immune modulating properties. I came across the following patent from "Free Patents Online". Does anyone know how to get more info on this "patent"? Also, I seem to be reading that metronidazole may also have antiviral properties. Anyone know anything about this? My daughter of the raspy throat, recently shared a drink with someone who was just dx'd with mono. I was revisiting cimetidine as a mono cure (as per Dr. Goldstein) and came across this other stuff that I'd forgotten about. Now I'm thinking perhaps it's time to revisit cimetidine in general, as well as metronidazole. Anyone have any success with Cimetidine or metronidazole against mono or other viruses or using it as an immunomodulator in general? penny Reagents and method for therapeutic treatment of multiple sclerosis Document Type and Number: United States Patent 5102902 Link to this page: http://www.freepatentsonline.com/5102902.html Abstract: The administration internally to humans of certain imidazol derivatives, especially N"-cyano-N-methyl-N'-[2[[(5-methyl-1H-imidazol-4-yl) methyl]thio]-ethyl]-guanidine (cimetidine) or salts thereof, is an effective therapeutic treatment for multiple sclerosis, both acute and chronic. The imidazole moiety is theorized to directly inhibit spread of the virus theorized to cause multiple sclerosis. Treatment of multiple sclerosis with metronidazole with one bolus dose on a frequency of once a day or less and with cimetidine on a frequency of twice per day has been found to be highly efficatious with minimal suppression of the patient's natural immune system and minimal long term peripheral nerve damage Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.